Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 539012

Levels of dipeptidyl peptidase IV/CD26 substrates neuropeptide Y and vasoactive intestinal peptide in rheumatoid arthritis patients


Buljević, Sunčica; Detel, Dijana; Batičić Pucar, Lara; Mihelić, Radovan; Madarević, Tomislav; Sestan, Branko; Varljen, Jadranka
Levels of dipeptidyl peptidase IV/CD26 substrates neuropeptide Y and vasoactive intestinal peptide in rheumatoid arthritis patients // Rheumatology international, 33 (2013), 11; 2867-2874 doi:10.1007/s00296-013-2823-z (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 539012 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Levels of dipeptidyl peptidase IV/CD26 substrates neuropeptide Y and vasoactive intestinal peptide in rheumatoid arthritis patients

Autori
Buljević, Sunčica ; Detel, Dijana ; Batičić Pucar, Lara ; Mihelić, Radovan ; Madarević, Tomislav ; Sestan, Branko ; Varljen, Jadranka

Izvornik
Rheumatology international (0172-8172) 33 (2013), 11; 2867-2874

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
dipeptidyl peptidase IV/CD26; neuropeptide Y; rheumatoid arthritis; vasoactive intestinal peptide

Sažetak
Neuropeptide Y (NPY) and vasoactive intestinal peptide (VIP) have their biological half-lives controlled by dipeptidyl peptidase IV (DPP IV/CD26). Several lines of evidence suggest the involvement of NPY in the regulation of rheumatoid arthritis (RA), and VIP has already been identified as a potent anti-inflammatory factor that reduces joint inflammation. The role of DPP IV/CD26 in the pathogenesis of RA has been indicated, but its mediator actions involving NPY and VIP have not been well investigated, so the aim of this study was to find an association between NPY, VIP, and DPP IV/CD26 in RA patients. Assessment of NPY, VIP, DPP IV/CD26 as well as some other inflammatory markers was carried out in 20 RA patients being treated with different types of drugs. Control group consisted of 18 osteoarthritis patients. Synovial fluid and serum content of investigated molecules was determined by ELISA and DPP IV/CD26 activity was measured spectrophotometrically. Immunodetection showed elevated levels of NPY and VIP in RA patients, with a significant increase in synovial fluid, while concentration and activity of DPP IV/CD26 were significantly decreased in both synovial fluid and serum. Positive correlations between serum DPP IV/CD26 concentration and activity (R = 0.6961), as well as between serum and synovial fluid concentration of VIP (R = 0.7029) were found. In RA group, NPY, VIP, and DPP IV/CD26 concentrations were not affected by the administration of drugs. The results of this study indicate a connection between elevated concentration of NPY and VIP and decreased DPP IV/CD26 activity and concentration, suggesting a potential role of these molecules in the immunomodulation of RA.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti



POVEZANOST RADA


Projekti:
062-0061245-0213 - Uloga dipeptidil-peptidaze IV (CD26/DPP IV) u kroničnim bolestima (Varljen, Jadranka, MZOS ) ( CroRIS)

Ustanove:
Medicinski fakultet, Rijeka

Poveznice na cjeloviti tekst rada:

doi link.springer.com

Citiraj ovu publikaciju:

Buljević, Sunčica; Detel, Dijana; Batičić Pucar, Lara; Mihelić, Radovan; Madarević, Tomislav; Sestan, Branko; Varljen, Jadranka
Levels of dipeptidyl peptidase IV/CD26 substrates neuropeptide Y and vasoactive intestinal peptide in rheumatoid arthritis patients // Rheumatology international, 33 (2013), 11; 2867-2874 doi:10.1007/s00296-013-2823-z (međunarodna recenzija, članak, znanstveni)
Buljević, S., Detel, D., Batičić Pucar, L., Mihelić, R., Madarević, T., Sestan, B. & Varljen, J. (2013) Levels of dipeptidyl peptidase IV/CD26 substrates neuropeptide Y and vasoactive intestinal peptide in rheumatoid arthritis patients. Rheumatology international, 33 (11), 2867-2874 doi:10.1007/s00296-013-2823-z.
@article{article, author = {Buljevi\'{c}, Sun\v{c}ica and Detel, Dijana and Bati\v{c}i\'{c} Pucar, Lara and Miheli\'{c}, Radovan and Madarevi\'{c}, Tomislav and Sestan, Branko and Varljen, Jadranka}, year = {2013}, pages = {2867-2874}, DOI = {10.1007/s00296-013-2823-z}, keywords = {dipeptidyl peptidase IV/CD26, neuropeptide Y, rheumatoid arthritis, vasoactive intestinal peptide}, journal = {Rheumatology international}, doi = {10.1007/s00296-013-2823-z}, volume = {33}, number = {11}, issn = {0172-8172}, title = {Levels of dipeptidyl peptidase IV/CD26 substrates neuropeptide Y and vasoactive intestinal peptide in rheumatoid arthritis patients}, keyword = {dipeptidyl peptidase IV/CD26, neuropeptide Y, rheumatoid arthritis, vasoactive intestinal peptide} }
@article{article, author = {Buljevi\'{c}, Sun\v{c}ica and Detel, Dijana and Bati\v{c}i\'{c} Pucar, Lara and Miheli\'{c}, Radovan and Madarevi\'{c}, Tomislav and Sestan, Branko and Varljen, Jadranka}, year = {2013}, pages = {2867-2874}, DOI = {10.1007/s00296-013-2823-z}, keywords = {dipeptidyl peptidase IV/CD26, neuropeptide Y, rheumatoid arthritis, vasoactive intestinal peptide}, journal = {Rheumatology international}, doi = {10.1007/s00296-013-2823-z}, volume = {33}, number = {11}, issn = {0172-8172}, title = {Levels of dipeptidyl peptidase IV/CD26 substrates neuropeptide Y and vasoactive intestinal peptide in rheumatoid arthritis patients}, keyword = {dipeptidyl peptidase IV/CD26, neuropeptide Y, rheumatoid arthritis, vasoactive intestinal peptide} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font